Fact-checked by Grok 2 weeks ago

Shellfish allergy

Shellfish allergy is an adverse triggered by specific proteins, such as , in , which includes crustaceans like , , and , as well as mollusks like clams, oysters, and . It is the most common among adults in the United States, affecting approximately 2.9% of adults (95% CI, 2.7%–3.1%), though varies globally, with estimates ranging from 0.5% to 10.3% depending on diagnostic methods, dietary habits, and geographic factors. The condition arises when the mistakenly identifies harmless proteins as threats, producing (IgE) antibodies that bind to these proteins upon exposure, leading to the release of and other chemicals. This reaction typically occurs within minutes to two hours after or contact and can manifest as mild symptoms including , itching, , or gastrointestinal upset, or escalate to severe ones such as swelling of the , , or throat, wheezing, dizziness, or —a potentially fatal systemic response involving shock and airway closure. Risk factors include a family history of allergies, being (in adults), or residing in regions with high consumption, such as coastal areas in where rates can reach up to 10.3%. Diagnosis involves a detailed of reactions, followed by skin prick testing to detect IgE responses or tests measuring specific IgE levels to shellfish proteins; in ambiguous cases, an oral under supervision may confirm the . primarily focuses on strict avoidance of and all products containing them, including reading food labels for hidden ingredients like shrimp-derived . For those at risk of severe reactions, carrying an epinephrine auto-injector (e.g., EpiPen) is essential, with immediate use recommended during followed by emergency . Unlike some allergies, shellfish allergy often persists lifelong and is not associated with iodine or reactions to radiocontrast media. Ongoing research explores desensitization therapies, but avoidance remains the cornerstone of prevention.

Overview

Definition and Classification

Shellfish allergy is defined as an immune reaction to proteins found in , primarily mediated by (IgE) antibodies, resulting in a response. This allergic condition triggers the rapid release of inflammatory mediators from mast cells and upon exposure to shellfish allergens, leading to clinical manifestations. It affects approximately 2-3% of adults worldwide, making it one of the most prevalent food allergies in this demographic. Shellfish are classified into two main groups for allergenic purposes: crustaceans and mollusks. Crustaceans include species such as , , , , and prawns, which possess jointed legs and a hard . Mollusks encompass bivalves like clams, oysters, mussels, and scallops; gastropods such as snails and ; and cephalopods including and . Allergies to crustaceans are more common than those to mollusks, with being the most frequently implicated across both children and adults. While there is potential for due to shared proteins like , allergies to one shellfish group do not invariably extend to the other, with a reported cross-reactivity rate of approximately 14% between crustaceans and mollusks. , crustacean shellfish has been recognized as one of the eight major food allergens under the Food Allergen Labeling and Act (FALCPA) since 2004, mandating clear labeling on packaged foods to protect consumers.

Distinction from Non-Allergic Reactions

Shellfish allergy is an IgE-mediated reaction requiring prior , whereas non-allergic reactions to , such as various forms of , result from direct exposure to toxins produced by and do not involve immune mechanisms. These poisonings can mimic allergic symptoms like , , and neurological effects, leading to frequent misdiagnosis, but they occur without prior exposure and are typically dose-dependent rather than repeatable upon re-exposure in sensitized individuals. Common non-allergic reactions include () caused by saxitoxins from dinoflagellates accumulated in bivalve mollusks, which leads to rapid-onset , , and potentially respiratory within minutes to hours after . Amnesic shellfish poisoning (ASP), due to from diatoms, presents with gastrointestinal distress followed by memory loss, confusion, and seizures up to 48 hours post-consumption. Scombroid poisoning, though more associated with finfish, can occur with spoiled shellfish via bacterial production and causes flushing, headache, and hypotension resembling , but lacks IgE involvement. These toxin-mediated events affect multiple people from the same contaminated batch, contrasting with the individualized nature of true allergies. In the United States, food allergies account for approximately 30,000 annual emergency department visits due to anaphylaxis, with shellfish being a leading trigger among adults. In contrast, shellfish poisonings are far less common, with typically fewer than 200 reported PSP cases nationwide annually and rare fatalities, highlighting their separation from allergic epidemiology. Ongoing surveillance by agencies like the FDA and CDC through toxin testing in shellfish helps distinguish these events. Diagnostic differentiation relies on clinical history—such as shared meal outbreaks for poisonings versus recurrent personal reactions for allergies—along with specific tests: enzyme-linked immunosorbent assays (ELISA) for detecting saxitoxins in blood or shellfish tissue for PSP, versus skin prick tests or serum IgE measurements for allergy confirmation.

Signs and Symptoms

Mild and Moderate Reactions

Mild and moderate reactions to shellfish allergy involve non-life-threatening symptoms that primarily affect the skin, oral cavity, , and gastrointestinal system, facilitating early recognition and intervention to avoid progression. Common symptoms encompass oral itching, (urticaria), eczema flare-ups, , sneezing, and mild gastrointestinal upset including , , and . These manifestations typically arise within minutes to two hours following exposure to shellfish allergens. Illustrative cases include an itchy mouth developing soon after eating or a skin rash appearing from handling . Among sensitized individuals, shellfish allergy can exacerbate , leading to intensified eczema lesions. Such reactions may occasionally escalate to more severe presentations if not addressed promptly.

Severe Reactions

Severe reactions to shellfish allergy primarily manifest as , a systemic and potentially life-threatening condition involving multiple organ systems. Key features include respiratory distress such as difficulty breathing due to airway constriction or throat swelling, cardiovascular effects like rapid heartbeat () and a sudden drop in blood pressure () leading to or fainting, and in severe cases, loss of consciousness. Gastrointestinal symptoms, including and severe abdominal cramps, often accompany these, while cutaneous signs like or widespread swelling may occur simultaneously. In shellfish-induced , symptoms such as a hoarse voice from laryngeal edema and pale or blue skin pallor () indicating poor oxygenation underscore the urgency of intervention. Shellfish allergy poses a higher risk of in adults compared to children, reflecting its prevalence as a persistent in this demographic. Notably, shellfish accounts for approximately one-third of adult food-induced cases, highlighting its significant contribution to severe allergic emergencies. A critical aspect of shellfish anaphylaxis is the potential for biphasic reactions, where symptoms recur 4 to 12 hours after the initial episode without further , necessitating prolonged monitoring. These severe responses often progress rapidly from milder precursors like itching or , emphasizing the need for immediate recognition of escalating symptoms.

Causes and Triggers

Direct Consumption

Direct consumption of represents the primary route of exposure for individuals with shellfish allergy, where of allergenic proteins leads to their absorption through the and subsequent systemic allergic responses. Upon eating , these proteins are processed in the digestive system, allowing fragments to cross the gastrointestinal mucosa and enter the bloodstream, potentially triggering reactions that affect multiple organ systems. Common scenarios for direct consumption include intentional meals featuring shellfish, such as shrimp in sushi, lobster at restaurants, or crab in stir-fries, where individuals may consume substantial portions without realizing the risk. Shellfish can also appear hidden in processed foods, like fish stock used in soups, seafood flavoring in sauces, or surimi in imitation crab products, increasing the chance of unintended ingestion. Crustacean shellfish must be labeled under U.S. food allergen laws, but mollusks like oysters or clams may not always be explicitly disclosed, complicating avoidance. Even small amounts of shellfish pose significant risks, as trace quantities—such as residues in shared cooking equipment or minimal inclusions in sauces—can provoke severe in sensitized individuals. Cooking does not destroy the allergenic proteins, meaning both raw and prepared carry equal potential for triggering symptoms. The primary allergens involved, such as , remain stable under typical cooking conditions. Sensitization to often occurs in adulthood through direct during meals, distinguishing it from allergies that typically develop in childhood. This later onset is linked to increased exposure opportunities in adult diets, such as dining out or trying new cuisines, making shellfish the most common among adults.

Cross-Contamination and Inhalation

Cross-contamination, also known as cross-contact, occurs when allergens transfer to non- foods or surfaces during preparation, posing a to allergic individuals even without direct . This can happen through shared cutting boards, utensils, or cooking equipment, such as when residue adheres to a used for other foods. In settings, are frequently stored or prepared alongside other ingredients, increasing the likelihood of unintended transfer during handling or cooking processes. Inhalation represents another indirect exposure route, where allergenic proteins from become aerosolized in , vapors, or particles during cooking methods like , , or . These airborne particles can trigger respiratory symptoms, such as wheezing or , in sensitive individuals located nearby, as shellfish proteins are potent aeroallergens capable of provoking reactions upon . For instance, wet aerosols released from snow or similar have been documented to cause responses in enclosed environments. Reactions from cross-contamination and are particularly noted in high-exposure settings like kitchens or , where odors from cooking may carry allergens into dining areas. Individuals in proximity to these activities, including restaurant patrons or staff, face elevated risks, with occupational parallels observed in seafood processing where aerosolized particles contribute to frequent sensitizations. To mitigate these exposures, using separate utensils for shellfish preparation is recommended, though comprehensive avoidance strategies extend beyond this measure.

Occupational Exposure

Occupational exposure to allergens poses significant risks to workers in the industry, particularly fishermen, shellfish processors, and chefs handling crustaceans such as and prawns or molluscs like mussels. These professions involve frequent with raw or processed shellfish, leading to sensitization through of aerosolized proteins during harvesting or processing and direct during manual handling. In processing plants, bioaerosols generated from cutting or boiling shellfish release high-molecular-weight allergens like , while chefs face repeated bare-handed manipulation in kitchen environments. Common symptoms in these settings include respiratory manifestations such as , wheezing, , , and from inhaled allergens, alongside cutaneous reactions like protein contact dermatitis, urticaria, and chronic from dermal exposure. Fishermen and processors may develop work-related asthma or ocular-nasal symptoms during peak harvesting seasons, while chefs often report recurrent blistering rashes or itching on the hands, wrists, and forearms. In atopic individuals, non-cutaneous effects like can accompany skin symptoms, and severe cases may progress to . Prevalence of occupational shellfish allergy is markedly higher among these workers than in the general population, with affecting 4–36% of shellfish processors and occurring in 3–11%. For instance, rates of approximately 15% in snow crab processing cohorts, and chefs show elevated incidence, with case series reporting multiple instances among culinary professionals compared to fewer among fishermen, who benefit from protective gloves. Sensitization often progresses from initial irritant responses—such as irritation from proteolytic enzymes or toxins mimicking early allergic symptoms—to full IgE-mediated with prolonged exposure. This evolution is influenced by exposure duration, intensity, and personal factors like , underscoring the chronic nature of occupational risks in these roles.

in shellfish allergy primarily arises from structural similarities in , a pan-allergen protein found in and various non-shellfish sources, leading to IgE-mediated responses to unrelated allergens. from crustaceans shares approximately 75% sequence identity with tropomyosin in house dust mites (Der p 10) and (Bla g 7), resulting in sensitization rates of up to 75% among shellfish-allergic individuals to these aeroallergens. Clinically, while to dust mites or is common in shellfish-allergic patients, many cases remain , with only 10-20% progressing to overt allergic symptoms upon exposure to the cross-reacting . For instance, immunotherapy has shown potential to reduce shellfish-specific IgE levels and skin test reactivity, as demonstrated in a 2025 study where participants experienced desensitization to after one year of treatment. This highlights the therapeutic implications of targeting shared epitopes. Notable examples include allergic reactions to land snails ( species), where up to 79% of sensitized individuals show with , often manifesting as respiratory or oral symptoms. Similarly, certain parasites like Anisakis simplex (a found in marine environments) can elicit reactions due to tropomyosin homology, though these are rarer and typically linked to raw consumption. Within shellfish groups, between crustaceans (e.g., , ) and mollusks (e.g., oysters, clams) is relatively low at about 14%, allowing some patients to tolerate one subgroup despite to the other. In diagnostic testing, positive IgE results to non-shellfish tropomyosins, such as those from dust mites or , are frequently observed without corresponding clinical symptoms, complicating interpretation and emphasizing the need to correlate with exposure history.

Cofactors

Cofactors are environmental or physiological factors that can exacerbate allergic reactions to in sensitized individuals without independently causing the . These factors lower the reaction threshold, leading to more severe symptoms upon exposure to shellfish allergens. In the context of shellfish , cofactors are implicated in a subset of anaphylactic events, particularly those involving crustaceans like and prawns. Exercise is a prominent cofactor in shellfish allergy, manifesting as food-dependent (FDEIA), where symptoms arise only when follows ingestion of the . The first documented case of FDEIA involved a who developed after eating oysters followed by strenuous exercise, highlighting the synergistic effect. Subsequent reports have identified , including , as triggers in FDEIA, with reactions occurring during activities such as running or within 1-4 hours of consumption. For instance, in cohorts, are among the leading causes of FDEIA, affecting both adults and children. These episodes are rare but can be life-threatening, often presenting with urticaria, , and during exertion. Other cofactors associated with heightened shellfish reactions include alcohol consumption, nonsteroidal anti-inflammatory drugs (NSAIDs), and infections. Alcohol can potentiate reactions by increasing gastric acidity and absorption, with case reports noting severe after shellfish intake followed by alcohol, even without exercise. NSAIDs, such as aspirin, exacerbate symptoms in up to 25% of cofactor-enhanced cases, including those involving shellfish, by inhibiting synthesis and promoting degranulation. Infections, particularly respiratory or gastrointestinal, lower the reaction threshold through and mucosal barrier disruption, contributing to 2-3% of pediatric events. The mechanisms underlying these cofactors involve enhanced allergen uptake and immune activation. Exercise induces gut ischemia and epithelial stress, increasing and allowing greater absorption of shellfish , a key . Alcohol and NSAIDs similarly elevate permeability and stimulate and responses, while infections amplify release, further sensitizing the . These processes explain why reactions may occur at lower allergen doses in the presence of cofactors.

Pathophysiology

Immune Mechanisms

Shellfish allergy is classified as a reaction, an IgE-mediated immune response that involves two distinct phases: and effector. During the phase, initial exposure to shellfish allergens leads to the of antigen-presenting cells, which stimulate + T helper 2 (Th2) cells. These Th2 cells release cytokines such as interleukin-4 (IL-4) and IL-13, promoting B-cell class switching to produce allergen-specific IgE antibodies. The IgE then binds to high-affinity FcεRI receptors on the surface of mast cells and , priming the for future encounters without causing immediate symptoms. Upon re-exposure to the , the effector phase is triggered as the proteins cross- the bound IgE molecules on sensitized mast cells and , leading to rapid . This releases preformed mediators like , as well as newly synthesized ones including leukotrienes and prostaglandins, which induce immediate symptoms such as , increased , and smooth muscle contraction. The Th2-driven process underscores the allergic , with IL-4 and IL-13 not only facilitating IgE production but also enhancing mucosal inflammation and recruitment. Allergic reactions in shellfish allergy can exhibit a biphasic pattern, consisting of an early occurring within minutes of due to , followed by a late several hours later. The late phase involves the recruitment of and other inflammatory cells, perpetuated by Th2 cytokines, resulting in prolonged symptoms without further . Unlike many other food allergies, such as those to or eggs, shellfish allergy tends to persist into adulthood due to the inherent of its allergens, which resist from heat, digestion, or processing, thereby maintaining long-term .

Key Allergens

The primary allergen responsible for shellfish allergy is , a heat-stable muscle protein with a molecular weight of approximately 36-38 kDa that is highly conserved across and species. In , it is designated as Pen a 1 in brown shrimp (Penaeus aztecus) and Pen m 1 in black tiger (Penaeus monodon), where it elicits IgE responses in the majority of affected individuals. This protein's structural conservation enables broad recognition by the , making it the dominant trigger in both crustaceans (e.g., , , ) and mollusks (e.g., , oyster). Other notable allergens include arginine kinase, identified as Pen m 2 in black tiger shrimp with a molecular weight of about 40 kDa, which binds IgE in 10-51% of shrimp-allergic patients and contributes to allergic sensitization. Myosin light chain, such as Lit v 3 in (Litopenaeus vannamei), is another recognized allergen, detected by IgE in over 50% of tested shrimp-allergic sera. In mollusks, additional allergens beyond tropomyosin variants (e.g., Cra g 1 in ) are less prevalent, with tropomyosin remaining the predominant molecular target. Shellfish allergens, particularly , exhibit remarkable stability, resisting denaturation from cooking, boiling, or freezing, which allows them to persist in processed foods and provoke reactions even after preparation. This thermostability arises from the protein's alpha-helical coiled-coil structure, ensuring allergenicity in both raw and cooked forms. Recent research as of 2025 has focused on developing variants of for potential immunotherapeutic applications, including mutated forms that reduce IgE binding while retaining T-cell stimulatory properties to induce . These engineered proteins, derived from and sources, show promise in preclinical models for desensitization therapies.

Diagnosis

Clinical History and Examination

The diagnosis of shellfish allergy begins with a thorough clinical history, which is essential for identifying patterns suggestive of an IgE-mediated reaction. Key elements include the timing of symptom onset, typically occurring within minutes to two hours after exposure to , such as crustaceans (e.g., , ) or mollusks (e.g., oysters, ). Patients should be queried about prior reactions, including the severity and specific symptoms experienced, as recurrent episodes following shellfish ingestion strongly indicate . A family history of atopic diseases, such as or eczema, increases the likelihood of shellfish allergy, with heritability estimates around 0.54 based on twin studies. Additionally, the presence of cofactors like exercise, , or nonsteroidal anti-inflammatory drugs should be assessed, as they can exacerbate reactions in susceptible individuals. Physical examination complements the history by focusing on objective signs of acute or recent allergic involvement. Vital signs are evaluated for indicators of anaphylaxis, including hypotension, tachycardia, or weak pulse, which signal systemic involvement. Skin inspection reveals common manifestations such as urticaria (hives), angioedema, or flushing, often appearing rapidly after exposure. Respiratory assessment includes auscultation for wheezing, stridor, or dyspnea, particularly in patients with a history of asthma, as coexisting respiratory conditions heighten reaction severity. The exam is typically normal in non-acute settings but guides the urgency of further evaluation. Red flags in the history and examination include recurrent episodes clearly linked to shellfish meals or severe features like airway compromise, which warrant immediate specialist referral. To differentiate shellfish allergy from non-allergic mimics, such as food intolerance or toxic reactions (e.g., scombroid poisoning), the timeline is critical: IgE-mediated allergies produce immediate symptoms, whereas intolerances often involve delayed gastrointestinal effects without systemic signs. This initial assessment establishes suspicion but requires confirmation through subsequent testing.

Laboratory and Challenge Testing

Laboratory and challenge testing provide objective confirmation of IgE-mediated to shellfish allergens, complementing clinical history by assessing the presence and severity of allergic responses. These tests are essential for distinguishing true from sensitization without clinical relevance, particularly in cases of potential with environmental allergens like dust mites or . Skin prick testing (SPT) is a widely used method to evaluate immediate to . The procedure involves applying fresh or commercial extracts of , such as or , to on the or back, followed by a shallow prick with a to introduce the . A positive reaction, indicated by a wheal diameter greater than 3 mm compared to a negative (e.g., saline), is typically observed within 15 to 30 minutes. For , fresh extracts prepared by the raw directly onto (prick-to-prick method) are often preferred due to the limited availability and variable potency of commercial extracts, which can lead to false negatives. SPT has high negative predictive value, meaning a negative result reliably rules out , but positive results require correlation with symptoms as they may reflect asymptomatic . Serum-specific IgE (sIgE) testing measures allergen-specific immunoglobulin E antibodies in the blood, offering a safe alternative to skin testing, especially for patients on antihistamines or with severe skin conditions. The ImmunoCAP system, a fluoroenzyme immunoassay, is the most commonly used platform and quantifies sIgE levels in kUA/L to various shellfish extracts, including shrimp (f24) and crab. A level greater than 0.35 kUA/L is generally considered positive for sensitization, though predictive thresholds for clinical allergy vary; for example, in non-dust mite-allergic individuals, shrimp sIgE exceeding 3.55 kUA/L provides high sensitivity (100%) for confirming allergy, with general shrimp sIgE offering a positive predictive value up to 86%. These tests help predict challenge outcomes but must be interpreted alongside history, as elevated sIgE can occur in cross-reactive conditions. The oral food challenge (OFC) remains the gold standard for diagnosing shellfish allergy, directly assessing clinical reactivity under medical supervision. Conducted in a controlled setting with emergency equipment available, it involves incremental doses of (e.g., cooked ) administered either openly or in a double-blind placebo-controlled manner (DBPCFC) to minimize bias. Doses start small and escalate based on tolerance, with reactions ranging from mild urticaria to observed and treated promptly. is particularly useful when SPT or sIgE results are equivocal, confirming allergy in about 20-30% of sensitized individuals without prior symptoms, though it carries risks and is avoided in high-risk cases. Component-resolved diagnostics (CRD) enhance precision by measuring IgE to individual components, aiding in the differentiation of primary shellfish allergy from . Using platforms like ImmunoCAP or multiplex arrays (e.g., ISAC), tests target key shellfish proteins such as (e.g., rPen a 1 from ), which is detected in over 80% of allergic patients and shows high specificity (up to 92.8%) for predicting clinical reactivity. -specific IgE levels help assess with like or mites, where exceeds 80%, guiding whether avoidance should extend beyond shellfish. CRD improves diagnostic accuracy over whole-extract tests, with tropomyosin IgE offering a positive predictive value of 72% for allergy.

Management

Avoidance Strategies

Avoidance of shellfish is the primary and most effective strategy for managing shellfish allergy, as it prevents allergic reactions by eliminating exposure to triggering proteins such as found in crustaceans and mollusks. Patients must adopt a multifaceted approach that includes vigilant label reading, awareness of hidden sources, and modifications to daily routines at home and when dining out. This comprehensive avoidance not only reduces the risk of immediate symptoms like or but also supports long-term . In dietary practices, individuals should strictly avoid all forms of crustacean shellfish, including , , , and , while consulting an allergist to determine if mollusks like clams, oysters, or scallops can be tolerated, as occurs in only about 14% of cases. Food labels must be scrutinized for the term "crustacean shellfish," which is required under the U.S. Food Allergen Labeling and Act (FALCPA) for packaged foods regulated by the FDA, though mollusks are not mandated as a major and may appear under other names. Hidden sources pose significant risks; for example, supplements derived from shellfish shells may contain trace allergens, and (imitation used in or salads) often includes shellfish extracts for flavoring, necessitating avoidance unless verified as shellfish-free. Additionally, shellfish derivatives can appear in fish stock, , or flavorings, requiring patients to contact manufacturers for clarification on ingredients. When dining out, proactive communication is essential: inform restaurant staff about the allergy upon arrival, request details on preparation methods, and avoid shared cooking equipment like fryers where shellfish residues could cause cross-contamination. Seafood restaurants or buffets carry high risks due to airborne vapors from or shellfish, which can trigger respiratory symptoms even without ingestion. Mobile apps such as AllergyEats or Spokin can assist by rating s for allergen-friendliness and providing menu translations for travel, helping users identify safer options based on user reviews and allergen policies. At home, preventing cross-contamination is critical through dedicated cookware, cutting boards, and utensils for non-shellfish meals, washed separately with hot, soapy water or in a to remove residues. If handling shellfish is unavoidable for household members, wearing disposable gloves and ensuring thorough cleaning of surfaces afterward minimizes transfer risks, though allergic individuals should ideally avoid direct contact altogether. Patient education forms the foundation of successful avoidance, with allergists providing training on identifying hidden allergens, interpreting labels, and recognizing early reaction signs to enable prompt action. Recent guidelines, including those from the European Academy of Allergy and Clinical Immunology (EAACI) updated in alignment with 2025 research, underscore the importance of avoiding even trace amounts of shellfish proteins in processed foods to prevent sensitization and severe reactions. Resources like dietitian consultations and support groups further empower patients to maintain a balanced, allergen-free diet.

Acute Reaction Treatment

The immediate treatment of acute reactions to shellfish allergy, particularly anaphylaxis, prioritizes the administration of intramuscular epinephrine as the first-line intervention. Epinephrine auto-injectors delivering 0.3 mg for adults and children weighing more than 30 kg, or 0.15 mg for children weighing 15 to 30 kg, are administered into the anterolateral , with repeat doses every 5 to 15 minutes if symptoms persist or recur. This rapid intervention reverses life-threatening symptoms such as , airway compromise, and cardiovascular collapse associated with . Supportive therapies are initiated after epinephrine to address residual symptoms but do not replace it. Antihistamines, such as diphenhydramine at 1 mg/kg intravenously or orally (maximum 50 mg for adults), help alleviate and itching, while blockers like famotidine may be added for enhanced effect. Corticosteroids, for example 1 to 2 mg/kg orally or 1 mg/kg intravenously, are used to prevent biphasic reactions, though their onset is delayed. Bronchodilators, such as albuterol via , are recommended for patients experiencing wheezing or . In an emergency, activate medical services by calling immediately upon recognizing , position the patient supine with legs elevated if hypotensive and breathing adequately, or in a if , and continuously monitor including airway, breathing, and circulation. Patients should remain under observation for at least 4 to 6 hours post-treatment due to the risk of biphasic reactions. All individuals diagnosed with shellfish allergy, given its high potential for severe reactions, should receive a prescription for two epinephrine auto-injectors, along with training on their use and an emergency action plan.

Long-Term and Emerging Therapies

For patients with mild shellfish allergy symptoms, daily administration of antihistamines such as loratadine can help manage occasional mild reactions like or itching by blocking . In severe or recurrent cases, , a monoclonal , offers a long-term option by binding free IgE to prevent and reduce reaction severity; it was FDA-approved in 2024 for reducing allergic reactions in multiple food allergies, with potential extrapolated benefits for shellfish due to its , based on trials showing increased thresholds for common allergens like and tree nuts. Clinical trials, such as NCT03881696, have demonstrated omalizumab's efficacy in desensitizing patients to various food allergens when used as monotherapy or adjunct to , with fewer adverse effects than oral approaches. In March 2025, stage 2 of the OUtMATCH trial reported omalizumab's superior efficacy over oral in multi-food allergies, with fewer adverse events. Immunotherapy approaches for shellfish allergy remain largely experimental but target key immune mechanisms like IgE-mediated responses to , the primary . Subcutaneous (SCIT) using shellfish extracts has shown promise in small studies, reducing symptoms and IgE levels, though it is not yet standardized due to variability in extracts. Oral (OIT) for , a common shellfish , achieved desensitization in 58.3% of participants in a phase 2 trial (MOTIF, NCT03504774), with 87.5% maintaining sustained unresponsiveness after avoidance; adverse events were mostly mild, occurring in 75% of cases without severe reactions. -based immunotherapies, including modified recombinant forms, aim to induce by altering IgE-binding epitopes, with preclinical models demonstrating reduced hypersensitivity. (HDM) provides cross-benefits for some shellfish-allergic individuals due to tropomyosin ; a 2025 study reported negative skin prick tests and lower shrimp-specific IgE in sensitized patients after one year of HDM SCIT, though food challenge varied. Emerging therapies focus on innovative delivery and allergen modification to improve safety and efficacy beyond traditional methods. DNA vaccines encoding variants of , such as pMEM49 (with 49 point mutations) or pMED171 (with deleted IgE ), have reduced allergic symptoms, IgE levels, and inflammation in mouse models by inducing regulatory T cells; pMED171 notably enhanced gut-homing Tregs and suppressed scores from 3.5 to 0.0. variants, created via or deletion (e.g., VR9-1 reducing IgE potency by 90-98%), are being explored for safer protocols. Epicutaneous (EPIT), using skin patches to deliver allergens via intact skin, shows potential for food allergies by promoting tolerance through dermal dendritic cells, though shellfish-specific trials are lacking; ongoing research suggests applicability to persistent allergens like . The global shellfish allergy therapeutics market is projected to reach $1.46 billion by 2025, driven by advancements in biologics and immunotherapies. Challenges in long-term therapies for shellfish allergy stem from its high persistence rate, with up to 80% of cases lasting into adulthood compared to higher resolution in or allergies. This durability limits success, as among shellfish species and inconsistent extract quality complicate dosing and outcomes, resulting in lower desensitization rates (e.g., 50-60% in OIT) versus 80%+ for non-seafood foods. Ongoing emphasizes standardized tropomyosin-targeted approaches to overcome these barriers.

Prognosis

Persistence and Resolution Rates

Shellfish allergy is characterized by high persistence rates, with approximately 70% to 84% of cases diagnosed in childhood continuing into adulthood. This contrasts with allergies to or , which are outgrown in 80% to 90% of children by . In comparison, only about 20% of individuals with shellfish allergy achieve natural resolution over time. Adult-onset shellfish allergy is common, often emerging in or later, and exhibits even lower remission rates, with fewer than 10% of cases resolving spontaneously. The annual resolution rate for shellfish allergy is estimated at less than 1%, underscoring its lifelong nature in the majority of affected individuals. Due to the potential for rare resolution, periodic re-evaluation through skin prick testing, serum IgE measurement, or oral food challenges is recommended for patients, particularly those with childhood onset, to monitor for loss of sensitivity.

Influencing Factors

Comorbidities, particularly atopic conditions, significantly worsen the of shellfish allergy by increasing reaction severity and complicating management. , such as and eczema (), is linked to higher odds of persistent shellfish allergy and more severe outcomes, with present in 23.2% of affected adults compared to 12.3% in the general . similarly elevates risk, with odds ratios for severe reactions reaching 2.5 in those with the condition. further complicates , as up to 70.2% of mollusk-allergic individuals also react to crustaceans due to shared allergens like , and additional to house dust mites can exacerbate symptoms through environmental exposure. Age at onset and gender also affect persistence, with late-onset cases and female gender associated with lower rates. Shellfish allergy frequently emerges in or adulthood, with a mean age of 17.7 years and adult-onset averaging 28.3 years, leading to higher persistence since childhood-onset allergies are more likely to resolve. Females exhibit a 1.5 times higher of developing shellfish allergy (65.0% of cases), potentially due to hormonal or immunological factors, contributing to prolonged disease course. Lifestyle factors, including adherence to avoidance strategies, may support resolution in select cases by minimizing and allowing natural to develop. Strict avoidance reduces exposure risks and has been shown to enable in a subset of patients upon reassessment, though overall resolution remains low at around 3.9% after 5–10 years for shellfish allergy.

Epidemiology

Prevalence and Incidence

Shellfish allergy is estimated to affect 0.5% to 3% of adults globally, positioning it as the leading cause of in this demographic. In children, the is generally lower, ranging from 0.1% to 2%. These figures vary based on diagnostic criteria, with self-reported rates often higher than those confirmed by clinical testing. The incidence of shellfish allergy is on the rise, particularly in populations, with self-reported among U.S. adults increasing from 2.6% in 2002 to 2.9% in 2022. This trend contributes to heightened concerns, as shellfish allergy accounts for a significant portion of the approximately 30,000 annual U.S. visits for food-induced . Shellfish allergy typically manifests with adult onset more frequently than in childhood, reflecting patterns of cumulative exposure to . Among specific triggers, is the most common culprit, with a 2025 meta-analysis reporting a pooled of 1.9% for shrimp allergy across self-reported symptomatic, physician-diagnosed, and testing-confirmed cases. Underreporting likely inflates the true burden, especially in areas with high seafood consumption where frequent exposure may normalize mild reactions or delay diagnosis. Occupational exposure in seafood-related industries can further complicate reporting, though it represents a subset of cases.

Geographic and Demographic Variations

Shellfish allergy prevalence exhibits notable geographic variations, largely influenced by dietary habits and exposure levels. In Southeast Asia, where seafood consumption is high, rates are elevated; for instance, in Singapore, the prevalence among older children (14-16 years) reaches 5.23%, reflecting the region's staple diet rich in crustaceans. Similarly, self-reported shellfish allergy affects up to 7.7% of adults in the Asia-Pacific region, with leading causes in countries like Thailand and Taiwan due to frequent ingestion. In contrast, inland and non-coastal areas show lower rates, such as reduced mollusk allergy in U.S. inland states compared to coastal regions, attributed to diminished dietary exposure. Globally, while overall prevalence hovers around 0.5-2.5%, coastal Southeast Asian populations experience 2-3 times higher sensitization than inland or Western counterparts. Demographic factors further modulate these patterns, with ethnic and gender differences prominent. Among U.S. adults, Asian individuals report the highest shellfish allergy rates at 3.8%, followed by (2.9%) and (2.5%) groups, exceeding non-Hispanic rates (2.2%), potentially linked to genetic predispositions and cultural dietary preferences. In pediatric cohorts, American children show significantly higher odds of shellfish allergy (adjusted 3.1) compared to children, alongside elevated finfish sensitization. Gender disparities reveal females comprising the majority of cases overall, particularly in adults (up to 65% female), though occupational exposure in seafood —often involving female workers—can elevate rates in both genders; conversely, male-dominated sectors like may contribute to higher in men through airborne allergens. Socioeconomic status influences and reported , with lower-income households correlating to higher rates, partly due to limited access to testing and confirmatory diagnostics. Seafood consumption patterns exacerbate this, as lower socioeconomic groups in urban coastal areas may have higher inadvertent exposure without medical oversight. Additionally, food insecurity amplifies disparities in low-resource settings. Recent trends indicate rising incidence, particularly in urbanizing regions of . As of 2025, data show shellfish allergy affecting approximately 3% of U.S. adults, with a noted uptick in pediatric cases linked to increased worldwide . In urbanizing Asian locales, such as southern China's , prevalence among schoolchildren stands at 5.1%—higher than rural areas—driven by dietary and expanded market access to . European registries also report escalating shellfish-induced in southern urban centers like and , underscoring a broader pattern of growth in developing urban economies with intensifying trade. A 2025 review highlights the rising tide of shellfish allergies in children globally, corresponding to increased rates.

Regulation

Food Labeling Requirements

In the United States, the Food Allergen Labeling and Consumer Protection Act (FALCPA) of 2004 mandates that food labels declare the presence of major food allergens, including crustacean such as , , , and , when they are intentionally added as ingredients. This declaration must appear either in the ingredient list using the common or usual name (e.g., "shrimp") or in a separate "Contains" statement specifying the source (e.g., "Contains: Crustacean Shellfish ()"). The 2025 FDA guidance on food labeling confirms these requirements remain unchanged for crustacean . Molluscan , such as oysters, clams, and mussels, are not classified as major food allergens under FALCPA and thus require only voluntary advisory labeling rather than mandatory declaration. In the , Regulation (EU) No 1169/2011 requires the labeling of 14 priority allergens in pre-packed foods, including both crustaceans (e.g., prawns, crabs) and molluscs (e.g., mussels, squid), when intentionally used as ingredients, regardless of quantity. These must be emphasized in the ingredients list through font, style, or color distinct from other ingredients, such as bolding "crustaceans" or listing specific examples like "shrimp extract." Unlike the U.S., the does not impose quantitative thresholds for mandatory declaration of most allergens, including shellfish; however, sulphites (sometimes associated with shellfish processing) must be labeled if exceeding 10 mg/kg or 10 mg/L. Internationally, the Commission's standards recommend mandatory declaration of eight major allergens in pre-packaged foods, aligning closely with the U.S. "Big 8" and including crustacean when intentionally added, to facilitate global trade and consumer safety. Examples of intentionally added shellfish components, such as "lobster stock" or "crab flavoring," must be clearly identified in ingredient lists under these frameworks to prevent allergic reactions. Enforcement of these labeling requirements is primarily handled by the U.S. (FDA), which conducts inspections, issues warning letters, and initiates recalls for products with undeclared crustacean shellfish, as these violations pose significant health risks. For instance, the FDA has recalled numerous products annually due to undeclared shellfish allergens, emphasizing compliance to protect consumers with allergies. In the EU, national authorities oversee compliance with Regulation 1169/2011, leading to similar enforcement actions for non-disclosure of shellfish allergens.

Workplace and Public Guidelines

In occupational settings, particularly for seafood processing workers at high risk of shellfish allergy due to repeated exposure, the (OSHA) recommends the use of (PPE) such as masks, gloves, and protective clothing to prevent dermal contact and inhalation of aerosolized allergens. Ventilation systems are also advised to reduce airborne particles in processing environments, aligning with OSHA's general respiratory protection standards under 29 CFR 1910.134, which require employers to provide respirators when necessary to protect employee health. Regarding allergy disclosure, OSHA interpretations protect employees from retaliation when reporting food allergies that could lead to work-related incidents, such as reactions during company-provided meals, and classify severe allergic responses as potentially recordable occupational illnesses if linked to workplace conditions. For restaurants and public dining establishments, the U.S. Food and Drug Administration (FDA) provides guidance through the Food Code, emphasizing staff training on identifying major like and preventing cross-contact via dedicated equipment, separate preparation areas, and thorough cleaning protocols. The (FAO) of the advises similar measures in public settings, including clear communication of allergen risks and structured handling practices to minimize exposure for patrons with allergies. Many U.S. restaurants voluntarily implement allergen menus or digital disclosures listing presence, a practice increasingly adopted by chains to enhance safety, as encouraged by FDA updates in the 2022 Food Code requiring awareness training that covers identification. Airline policies for passengers with shellfish allergies typically require advance notification—often 48 hours—to request special in-flight meals free of shellfish and other allergens, with major carriers like and offering options such as low-allergen or vegetarian meals that avoid shellfish. Passengers are generally advised to carry their own safe snacks, as airlines do not guarantee nut-free or allergen-free cabins but commit to crew training on emergency responses. In public health contexts, the Centers for Disease Control and Prevention (CDC) monitors outbreaks related to shellfish consumption, primarily focusing on toxin-induced illnesses like rather than allergic reactions, through systems such as the to inform prevention strategies.

References

  1. [1]
    Shellfish allergy - Symptoms and causes - Mayo Clinic
    Jul 2, 2024 · Shellfish allergy symptoms generally start within minutes to an hour after eating or having contact with shellfish. They may include: Hives.
  2. [2]
    Shellfish allergy | AAAAI
    An allergy to shellfish can result in symptoms of anaphylaxis (an-a-fi-LAK-sis), a life-threatening allergic reaction. An allergist / immunologist has advanced ...
  3. [3]
    Advances in Shellfish Allergy Therapy: From Current Approaches to ...
    Jul 16, 2025 · Shellfish-allergic individuals are suffering from a wide spectrum of symptoms, ranging from mild oral allergy syndrome (with limited oral ...
  4. [4]
    Not all shellfish "allergy" is allergy! - PMC - PubMed Central
    Most common symptoms are nausea, vomiting and diarrhea which resolve after 24 hours. Shellfish toxicity recognition and management. Shellfish poisoning may be ...
  5. [5]
    Prevalence of fish and shellfish allergy: A systematic review - PubMed
    The prevalence of fish allergy ranged from 0% to 7% and the prevalence of shellfish allergy from 0% to 10.3%, depending on the method of diagnosis.
  6. [6]
    Shellfish allergy - Diagnosis and treatment - Mayo Clinic
    Jul 2, 2024 · If you have a severe allergic reaction to shellfish (anaphylaxis), you'll likely need an emergency injection of epinephrine (adrenaline). If you ...
  7. [7]
    Type I Hypersensitivity Reaction - StatPearls - NCBI Bookshelf - NIH
    Aug 3, 2025 · The reaction occurs when antigen-specific IgE binds to mast cells and basophils, triggering the release of inflammatory mediators, including ...
  8. [8]
    IgE-Mediated Shellfish Allergy in Children - MDPI
    The IgE-mediated reactions occur within about two hours after ingestion of the shellfish and range from urticaria, angioedema, nausea, and vomiting to ...
  9. [9]
    Shellfish Allergy - an overview | ScienceDirect Topics
    Worldwide, there are fewer data on adults, with an estimate of 2.0% allergic to shrimp in Denmark27 and 3.3% in Taiwan.
  10. [10]
    Shellfish - FoodAllergy.org
    About 60 percent of people with shellfish allergy experience their first allergic reaction as adults. Shellfish can cause severe and potentially life- ...
  11. [11]
    Mollusk tolerance in crustacean‐allergic children: Unraveling ...
    Oct 24, 2025 · In fact, 14% of crustacean-allergic patients report having a mollusk allergy, while 60% of cephalopod-allergic patients and 40% of bivalve- ...
  12. [12]
    Food Allergen Labeling and Consumer Protection Act of 2004 - FDA
    Nov 29, 2022 · SEC. 202. FINDINGS. · (A) eight major foods or food groups--milk, eggs, fish, Crustacean shellfish, tree nuts, peanuts, wheat, and soybeans-- ...
  13. [13]
    Seafood Toxicity: Overview, Finfish Poisoning, Shellfish Poisoning
    Oct 15, 2025 · Histamine fish poisoning, also known as scombroid fish poisoning, results from the ingestion of improperly handled/stored finfish, such as tuna, ...
  14. [14]
    Restaurant Food Allergy Practices---Six Selected Sites... - CDC
    Apr 21, 2017 · Food allergies affect an estimated 15 million persons in the United States (1), and are responsible for approximately 30,000 emergency ...
  15. [15]
    Quantification of saxitoxin in human blood by ELISA - CDC stacks
    May 7, 2017 · Our laboratory has validated an enzyme-linked immunosorbent assay (ELISA) for quantitative detection of STX from 0.020 to 0.80 ng/mL in human ...<|control11|><|separator|>
  16. [16]
    Shellfish Allergy | Causes, Symptoms & Treatment | ACAAI Public ...
    Crustacean shellfish is one of the eight allergens that fall under the labeling requirements of the Food Allergen Labeling and Consumer Protection Act of 2004.Missing: major law
  17. [17]
    Shellfish Allergy | Anaphylaxis UK
    Crustaceans. Crustaceans include crab, lobster, crayfish and prawns. · Molluscs. Molluscs can be split up further into bivalves, gastropods and cephalopods.
  18. [18]
    Shellfish Allergy: Causes, Symptoms, Diagnosis & Treatment
    within a few minutes to a few hours. What ...
  19. [19]
    Shellfish allergy symptoms: How long they last and treatments
    Jun 25, 2019 · These symptoms can occur within minutes of ingesting shellfish, but they may sometimes not appear for several hours. There are two different ...Symptoms · Causes · Treatment · At home
  20. [20]
    Shellfish Allergen Facts, Symptoms, and Treatment | Allergy Insider
    Although food allergy symptoms can start a few minutes to several hours after ingestion, most begin within two hours.
  21. [21]
    Food allergy to shrimps and fish in patients suffering from atopic ...
    Fish allergy can lead to the exacerbation and worsening of the skinl esions in 4% of atopic dermatitis patients and shrimp allergy in 2% of atopic dermatitis ...
  22. [22]
    Characteristics of Fish and Shellfish Allergy
    Allergic rhinitis, eczema, and asthma were present in most seafood allergic patients (82.9%, 57.3%, and. 51.2% respectively). CONCLUSIONS: Most shellfish and ...<|separator|>
  23. [23]
    Fish, shellfish anaphylaxis in Europe differ in age, region - Healio
    Sep 19, 2025 · A higher proportion of adults vs. children/adolescents had shellfish-induced anaphylaxis (76% vs. 24%), whereas the opposite was true for fish- ...
  24. [24]
    Food Allergy & Anaphylaxis - Crustacean Shellfish | FAACT
    Shellfish allergy is an IgE antibody-mediated reaction to proteins found in crustacean or mollusk family shellfish and is a common cause of anaphylaxis of foods ...Other Sources Of Protein · Practical Tips · Shellfish In Unexpected...
  25. [25]
    Anaphylaxis | Causes, Symptoms & Treatment | ACAAI Public Website
    A second anaphylactic reaction, known as a biphasic reaction, can occur as long as 12-24 hours after the initial reaction. Unfortunately, reaction severity is ...Overview · Symptoms · Diagnosis
  26. [26]
    Anaphylaxis: Recognition and Management - AAFP
    Sep 15, 2020 · Patients should be monitored for a biphasic reaction (i.e., recurrence of anaphylaxis without reexposure to the allergen) for four to 12 hours, ...
  27. [27]
    Immunoglobulin E (IgE)-mediated food allergy - PMC - NIH
    Dec 30, 2024 · Following the ingestion of food, reactions can occur locally in the mouth and gut, or in distant organs, following the systemic absorption of ...<|control11|><|separator|>
  28. [28]
    Shellfish Allergy - StatPearls - NCBI Bookshelf
    Sep 26, 2022 · Other signs and symptoms associated with shellfish allergies are atopic dermatitis (eczema), coughing or sneezing, coryza, circumoral ...
  29. [29]
    Prevalence and characteristics of adult-onset food allergy - PMC - NIH
    As shown in Figure 2, the 5 most common food allergies determined, in decreasing order of frequency, were shellfish (54%), tree nut (43%), non-shell fish (15%), ...Missing: direct hidden cooking
  30. [30]
    Food hypersensitivity by inhalation - PMC - PubMed Central - NIH
    They can occasionally occur through inhalation. In a study of 197 children allergic to fish by ingestion, 21 showed symptoms by inhalation.Exposure Settings · Manifestations Of Food... · Asthma<|control11|><|separator|>
  31. [31]
    Shellfish Allergen Facts, Symptoms, and Treatment | Allergy Insider
    Avoid cross-contamination when cooking by using two sets of cooking and eating utensils, with one exclusively for the allergic individual. Wash all dishes and ...
  32. [32]
    Occupational seafood allergy: a review - PubMed
    Occupational allergies have been reported in workers exposed to arthropods (crustaceans), molluscs, pisces (bony fish) and other agents derived from seafood.
  33. [33]
    Exposures and Health Effects of Bioaerosols in Seafood Processing ...
    Aug 27, 2019 · Occupational asthma has been more commonly associated with shellfish (prevalence range: 4%–36%) than with bony fish (prevalence range: 2%–8%).
  34. [34]
    Occupational contact dermatitis from protein in sea products - NIH
    Feb 10, 2017 · Chefs (specifically those who work with seafood) appear to be at higher risk of occupational protein contact dermatitis than fishermen. The ...
  35. [35]
    Seafood allergies: Control, prevention key to workplace management
    Sep 1, 2007 · Masks and gloves help protect these workers from allergic reactions related to dermal contact with seafood and aerosol particles in the processing environment.Reactions To Seafood · Allergens · Health Effects
  36. [36]
    Food allergies and food-induced anaphylaxis: role of cofactors - PMC
    Cofactors such as exercise, infections, NSAID use, dehydration, and alcohol intake can increase intestinal permeability and result in increased antigen uptake, ...
  37. [37]
    Exercise-induced anaphylactic reaction to shellfish - PubMed
    This case study represents a previously undescribed late food hypersensitivity, induced only by strenuous exercise.
  38. [38]
    Exercise-induced anaphylactic reaction to shellfish - ScienceDirect
    This case study represents a previously undescribed late food hypersensitivity, induced only by strenuous exercise. Identification of this new syndrome ...
  39. [39]
    Identification of allergens for food-dependent exercise-induced ...
    Mar 8, 2021 · Crustaceans are common causes of immediate-type food allergy and food-dependent exercise-induced anaphylaxis (FDEIA). In Japan, the prevalence ...
  40. [40]
    Food-dependent exercise-induced anaphylaxis - PMC - NIH
    Many different types of foods have been shown to cause food-dependent exercise-induced anaphylaxis (FDEIA), including wheat, shellfish, nuts, tomatoes, peanuts ...
  41. [41]
    Do Antacids or Alcohol Trigger Shellfish Allergy in Adults?
    Oct 29, 2020 · However, alcohol is often a food allergy co-factor, meaning it can lower the threshold of reactivity to a food, as can illness, exercise, or ...Missing: NSAIDs | Show results with:NSAIDs
  42. [42]
    Food-Induced Anaphylaxis: Role of Hidden Allergens and Cofactors
    Cardona et al. evaluated 74 cases of suspected co-factor enhanced food allergy and reported that NSAID were involved in 58%, exercise in 52.7%, and alcohol in ...Missing: exacerbating shellfish
  43. [43]
    IgE-Mediated Food Allergy | Clinical Reviews in Allergy & Immunology
    Oct 29, 2018 · IgE-mediated food-allergic disease differs from non-IgE-mediated disease because the pathophysiology results from activation of the immune system.
  44. [44]
    IgE-Mediated Shellfish Allergy in Children - PMC - PubMed Central
    The most common allergenic proteins involved in IgE-mediated allergic reactions to shellfish include tropomyosin, arginine kinase, myosin light chain, ...
  45. [45]
    Overcoming Shellfish Allergy: How Far Have We Come? - MDPI
    Shellfish is one of the most common food allergens, and allergy to shellfish usually persists throughout life. This is different from allergies to hen's eggs ...
  46. [46]
    f351 Pen a 1, Tropomyosin, Shrimp - Thermo Fisher Scientific
    At least 13 allergens are found in extracts of cooked Brown shrimp, and the 36-kDa muscle protein tropomyosin (Pen a 1) has been identified as a major Shrimp ...
  47. [47]
    Characterization of Recombinant Shrimp Allergen Pen a 1 ... - PubMed
    Tropomyosin (Pen a 1) from brown shrimp, Penaeus aztecus, has been identified as the only major shrimp allergen. Since beef, pork and chicken are other ...
  48. [48]
    Shellfish allergens: tropomyosin and beyond - Wiley Online Library
    Dec 27, 2016 · Tropomyosin is considered to be the major allergen in shellfish allergy. Actually, already in the early 1980s Hoffman et al.
  49. [49]
    [PDF] Shellfish Allergy: Unmet Needs in Diagnosis and Treatment - JIACI
    Dec 9, 2020 · Yang et al [67] reported that in some cases of shrimp sensitization due to cross-reactivity with cockroaches, tropomyosin was not the dominant ...
  50. [50]
    Genomics of Shrimp Allergens and Beyond - MDPI
    After tropomyosin, AK has been identified as crustaceans' second most important allergen. It shows positive IgE binding in 10–51% of individuals with shrimp ...Genomics Of Shrimp Allergens... · 2. Shrimp Allergens... · 3. Shrimp Allergens...
  51. [51]
    Proteomics and immunological analysis of a novel shrimp allergen ...
    Pen m 2 was purified by anion exchange chromatography and shown to have arginine kinase activity and to react with serum IgE from shrimp allergic patients and ...
  52. [52]
    Myosin light chain is a novel shrimp allergen, Lit v 3 - PubMed
    We sought to identify relevant crustacean allergens for use as diagnostic and safe immunotherapeutic agents for subjects with shellfish allergy.
  53. [53]
    Hypoallergenic mutants of the major oyster allergen Cra g 1 ...
    At present, six shellfish allergens have been well explored, including tropomyosin, sarcoplasmic calcium-binding protein, arginine kinase, triose phosphate ...
  54. [54]
    [PDF] Allergic and Toxic Reactions to Seafood
    Cooking can sometimes affect tolerance. Seafood allergens are usually very heat stable and cannot easily be destroyed through cooking, although occasional ...
  55. [55]
    Relationship between the risk for a shrimp allergy and freshness or ...
    Tropomyosin is the major allergen in shrimps and prawns, and it has been characterized as a heat-stable allergen.Citation) Shrimp tropomyosins have highly ...Missing: shellfish freezing<|control11|><|separator|>
  56. [56]
    Advances in Shellfish Allergy Therapy: From Current Approaches to ...
    Jul 16, 2025 · This review discusses progress with allergen-specific immunotherapy, hypoallergenic allergen variants, DNA-based vaccines, and innovative approaches.
  57. [57]
  58. [58]
    Diagnosis of fish and shellfish allergies - PMC - NIH
    Oct 8, 2018 · Worldwide prevalence of shellfish allergy was found to be 0.6% with higher incidence reported in the Asia-Pacific region. In the USA, the ...Shellfish Allergens And... · Table 2 · Diagnosis Of Fish And...
  59. [59]
  60. [60]
    Diagnosis and management of shrimp allergy - Frontiers
    Oct 17, 2024 · Skin prick testing offers fast results at a relatively low cost and is known to have high negative accuracy, in which a lack of response is ...
  61. [61]
    Allergens and molecular diagnostics of shellfish allergy - NIH
    Nov 2, 2016 · Not only ingestion of shellfish can cause sensitization, but also exposure during processing in factories and domestic environment. There seems ...
  62. [62]
    Food Allergies | FDA
    Sep 22, 2025 · To protect people with food allergies, FDA enforces regulations requiring companies to list ingredients on packaged foods.Food Allergen Labeling and... · Guidance for Industry · Frequently Asked Questions
  63. [63]
    4 Food Allergy Apps to Help Keep You Safe - Verywell Health
    Feb 8, 2024 · AllergyEats allows you to use a “find near me” search for restaurants and returns a list ranked by allergy-friendly rating. If you're traveling ...Missing: strategies | Show results with:strategies
  64. [64]
    Avoiding Cross-Contact - FoodAllergy.org
    Learn how to prevent cross-contact, which happens when an allergen is accidentally transferred from one food to another.
  65. [65]
    Epinephrine (injection route) - Side effects & dosage - Mayo Clinic
    Aug 31, 2025 · Adults and children weighing 30 kilograms (kg) or more—0.3 to 0.5 milligram (mg) injected under the skin or into the muscle of your thigh. You ...Before Using · Proper Use · Dosing
  66. [66]
    Epinephrine Auto Injector | Symptoms & Treatment | ACAAI Public ...
    The first-line treatment for anaphylaxis is epinephrine (adrenaline). It is available by prescription in an auto-injector or nasal spray. A delay in using ...
  67. [67]
    Anaphylaxis - StatPearls - NCBI Bookshelf - NIH
    When anaphylaxis is diagnosed, co-treatment is often initiated with steroids, antihistamines, inhaled bronchodilators, and vasopressors. Glucagon can also ...
  68. [68]
    Anaphylaxis Treatment & Management - Medscape Reference
    Aug 16, 2024 · The standard treatment of anaphylaxis should also include antihistamines and corticosteroids. However, antihistamines have a much slower onset ...
  69. [69]
    Anaphylaxis: Emergency treatment - UpToDate
    Aug 12, 2025 · Epinephrine · - Dosing and administration · Intramuscular epinephrine injection (preferred) · IV epinephrine by slow bolus (use with caution) ...
  70. [70]
    Anaphylaxis: A 2023 practice parameter update
    Dec 17, 2023 · Therefore, epinephrine should be administered at the first sign or symptom of suspected anaphylaxis. However, there is no evidence that ...Missing: shellfish | Show results with:shellfish
  71. [71]
    Leukotriene Modifiers: Treatment & Definition - Cleveland Clinic
    Jun 2, 2021 · Leukotriene modifiers, or leukotriene receptor antagonists, are a group of medications that can help prevent asthma attacks and allergic ...Missing: shellfish | Show results with:shellfish
  72. [72]
    Can You Treat Shellfish and Fish Allergies? It's Starting to Happen
    Aug 21, 2025 · One study found that after a year of dust mite immunotherapy, some shrimp-sensitized patients had negative skin test reactions and lower shrimp- ...
  73. [73]
    Study Details | NCT03881696 | Omalizumab as Monotherapy and as ...
    This part of the study will assist investigators in learning if receiving omalizumab for a longer time may work better at decreasing allergic reactions. In ...
  74. [74]
    Shellfish Allergy Therapeutics 2025 Trends and Forecasts 2033
    Apr 28, 2025 · The global shellfish allergy therapeutics market is experiencing significant growth, projected to reach $1455.9 million in 2025.<|control11|><|separator|>
  75. [75]
    Risk Factors for Severe Seafood Allergy Among Adults in an Urban ...
    Mar 12, 2024 · Most participants with SFA developed their first reactions after 6 years of age, with the highest frequency of reactions reported at ages 11–16 ...
  76. [76]
    Allergic and toxic reactions to seafood
    Difficulty talking or hoarse voice; Persistent dizziness or collapse; Pale and floppy (in young children). Anaphylaxis is the most severe type of allergic ...
  77. [77]
    The Natural History and Risk Factors for the Development of Food ...
    Feb 28, 2024 · The prevalence of adult food allergy is at a historic high [79]. The most common allergies reported in adults are shellfish (2.9%), milk (1.9%), ...
  78. [78]
    People rarely outgrow seafood allergies - Reuters
    Oct 9, 2018 · "Seafood allergy rarely resolves - less than 1 percent resolution rate for either fish or shellfish allergy per year of follow up," Ben-Shoshan ...
  79. [79]
    PREVALENCE AND CHARACTERISTICS OF ADULT SHELLFISH ...
    Nov 1, 2020 · This updates national data collected in 2002, which reported adult SA prevalence rates of 2.6%, and also observed elevated rates among female ...
  80. [80]
    Advances in Shellfish Allergy Therapy: From Current Approaches to ...
    Jul 16, 2025 · As the primary target in current immunotherapy approaches, tropomyosin plays a central role in driving shellfish-induced immune responses.
  81. [81]
    What you need to know about shellfish allergy diagnosis, treatment
    Oct 6, 2022 · Symptoms may include vomiting, dizziness or fainting and trouble breathing due to constricted airways. In rare cases, without immediate ...
  82. [82]
    Prevalence and Characteristics of Shellfish Allergy in the Pediatric ...
    Mar 11, 2021 · Overall, the prevalence of SA was 1.3% (95% CI 1.1 – 1.5) with more children allergic to crustacean than mollusk at a prevalence of 1.2% (95% CI ...
  83. [83]
    Are the Number of Adults with Shellfish Allergies Increasing?
    Dec 26, 2022 · Research shows that nearly 3% of adults in our country are allergic to shellfish. Research Need. Food allergies can be difficult to ...
  84. [84]
    Prevalence of shrimp allergy: a meta-analysis based on different ...
    Results: The pooled prevalence was estimated at 1.90% for self-reported symptomatic SA and 1.94% for self-reported physician-diagnosed SA, while testing via ...
  85. [85]
    Food allergy in Singapore: opening a new chapter - PMC - NIH
    Shellfish is the most common food allergen in Singapore. The prevalence of shellfish allergy in older children is high at 5.23%,(11) reflecting a typical ...
  86. [86]
    Seafood Allergy in Asia: Geographical Specificity and Beyond
    Shellfish is one of the most common food allergen sources in Asia (Table 1), and the leading cause of food allergy in Taiwan (18, 19), Thailand (20), Singapore ...
  87. [87]
    Variations in shrimp allergens and place of origin can affect food ...
    May 20, 2024 · In general, heating (cooking) shrimp will usually result in a considerable degradation of labile allergens, and very heat-stable allergens ...
  88. [88]
    Racial, Ethnic, and Socioeconomic Differences in Food Allergies in ...
    Jun 14, 2023 · This survey study of a US nationally representative sample suggests that the prevalence of food allergies was highest among Asian, Hispanic, and non-Hispanic ...Missing: variations | Show results with:variations
  89. [89]
    African American children are more likely to be allergic to shellfish ...
    African American children are more likely to be allergic to shellfish and finfish: findings from FORWARD, a multisite cohort study
  90. [90]
    Prevalence of food allergy differs by race, ethnicity, income - Healio
    Jun 22, 2023 · Asian participants had the highest rates of peanut (2.9%; 95% CI, 2%-4.2%) and shellfish (3.8%; 95% CI, 3%-4.9%) allergies among adults.Missing: variations | Show results with:variations
  91. [91]
    Socioenvironmental factors associated with shrimp allergy and ...
    Compared to White individuals, rates of shrimp allergy were significantly higher in Black, Asian/Pacific Islander, Native American, and Latino individuals.
  92. [92]
    Sex Disparity in Food Allergy: Evidence from the PubMed Database
    Jul 2, 2009 · Whereas among children with food allergies, 64.35% were males and 35.65% were females (male/female ratio, 1.80), among adults 34.82% were males ...
  93. [93]
    Gender and snow crab occupational asthma in Newfoundland and ...
    Cross-referencing of work history results with allergen sampling data for male and female job areas showed a gender difference in median cumulative exposures ( ...
  94. [94]
    Socioeconomic Disparities Affect the Prevalence of Specific Food ...
    Wheat and Shellfish allergy were less common with household income > $150,000 [OR = 0.10 (95% CI: 0.02, 0.58)]. Shellfish [OR = 5.36 (95% CI: 2.99, 9.60)] ...
  95. [95]
    Socioeconomic disparities affect prevalence of specific food allergies
    Mar 20, 2023 · Children from households with incomes greater than $150,000 were less likely to have shellfish allergies. Perspective from Andrea Pappalardo ...
  96. [96]
    Disparities in pediatric seafood allergy by social determinants of health
    Oct 17, 2024 · We found differences in pediatric seafood allergy by race, socioeconomic status, and food insecurity status. In models adjusting for ...Missing: factors | Show results with:factors
  97. [97]
    Socioeconomic determinants of food allergy burden
    Jul 29, 2022 · US epidemiologic data indicate that food allergy management tends to be suboptimal among patients with lower socioeconomic status.
  98. [98]
    From delicacy to danger: The rising tide of shellfish allergies in ...
    Jun 13, 2023 · Following the rise in shellfish consumption rates throughout the world, a corresponding increase in shellfish allergy rates has also increased.Missing: remission | Show results with:remission
  99. [99]
    Europe's largest allergy registry reveals trends in seafood anaphylaxis
    Aug 27, 2025 · A study carried out on registry data from anaphylactic reactions between 2007 to 2022 identified 462 cases of seafood-induced anaphylaxis, ...
  100. [100]
    Trends in Seafood-Induced Anaphylaxis: Data From the European ...
    Aug 6, 2025 · Shellfish anaphylaxis was more common in adults (76%), particularly women, was not life-threatening and presented with an atopy-independent ...
  101. [101]
    Food Allergen Labeling Guidance for Industry - FDA
    Mar 26, 2025 · The guidance is intended to help the food industry meet the requirements for listing major food allergens (milk, egg, fish, Crustacean shellfish, tree nuts, ...
  102. [102]
    Food allergens - EFSA - European Union
    Apr 22, 2025 · People typically suffer from allergies to nuts, shellfish, and certain fruits. In the EU there are 14 food allergens that must indicated if they are used as ...
  103. [103]
    Food allergen labelling and information requirements technical ...
    Aug 23, 2023 · The rules require sulphur dioxide and/or sulphites to be labelled when present above 10 mg/Kg or 10 mg/litre (calculated in terms of the total ...<|control11|><|separator|>
  104. [104]
    Crustacean Shellfish | Food Allergy Research & Resource Program
    Crustacean shellfish is included in the Big-8 and the Codex Alimentarius allergen labeling recommendations for labeling of pre-packaged foods.
  105. [105]
  106. [106]
    [PDF] Sec. 555.250 Major Food Allergen Labeling and Cross-contact - FDA
    The purpose of this compliance policy guide (CPG) is to provide guidance for FDA staff on FDA's enforcement policy regarding major food allergen labeling and ...
  107. [107]
    Whole Foods Market Warned After Undeclared Allergens - FDA
    Dec 22, 2020 · Whole Foods Market has recalled more than 30 food products because the presence of major food allergens was not listed on the finished product labels.
  108. [108]
  109. [109]
  110. [110]
  111. [111]
    Retail Food Industry/Regulatory Assistance & Training - FDA
    Nov 21, 2024 · FDA provides regulatory assistance and training on topics such as allergens, time/temperature control, cross-contamination, employee health, ...
  112. [112]
    Food Allergen Cross-Contact Prevention | 360training
    Apr 10, 2025 · Prevent cross-contact by separating food, people, and equipment, or using strict decontamination. Staff training and proper handling during all ...
  113. [113]
    Food allergens | Food safety and quality
    The proteins in food that trigger allergic reactions are known as food allergens. Approximately 220 million people worldwide have food allergies.
  114. [114]
    On the Menu: Food Allergen Disclosures for Restaurants and Food ...
    Jan 19, 2023 · The U.S. Food and Drug Administration recently updated its FDA Food Code, requiring new obligations for disclosing major food allergens.
  115. [115]
    [PDF] Integrating FDA Food Code Changes into Your ServSafe Course
    The 2022 FDA Food Code clarifies that proper employee training in food allergy awareness must include the ability to identify the major food allergens as well ...
  116. [116]
    Allergies | United Airlines
    If your next flight has meal service and you have a food allergy, you may make a special meal request. Special meal options are limited and may not be available ...
  117. [117]
    Dietary Needs & Allergies | Delta Air Lines
    We offer a variety of special meals, like vegetarian, diabetic, low-sodium and low-cholesterol meals to comply with special dietary requirements on flights that ...
  118. [118]
    Flying With Allergies [Includes Nut Policies for 60 Airlines]
    Oct 16, 2025 · Passengers flying with allergies should notify the airline at least 48 hours in advance. Bring necessary medications like antihistamines and ...
  119. [119]
    Food Poisoning from Marine Toxins | Yellow Book - CDC
    Apr 23, 2025 · Scombroid poisoning resembles an acute allergic reaction and usually appears 10–60 minutes after a person eats contaminated fish. Signs and ...Missing: distinction | Show results with:distinction
  120. [120]
    Shrimp oral immunotherapy outcomes in the phase 2 clinical trial
    Jul 21, 2025 · Shrimp OIT is safe and effective for the treatment of shrimp allergy. Most participants were successful and achieved SU after 6 weeks of avoidance.